Outputs (2)

Investigating prescribers' experiences of direct-acting oral anticoagulants for the management of nonvalvular atrial fibrillation. (2020)
Thesis
GENERALOVA, D. 2020. Investigating prescribers' experiences of direct-acting oral anticoagulants for the management of nonvalvular atrial fibrillation. Robert Gordon University, PhD thesis. Hosted on OpenAIR [online]. Available from: https://doi.org/10.48526/rgu-wt-1447131

Direct-acting oral anticoagulants (DOACs) have relatively recently been licensed for stroke and systemic embolism prevention in patients with non-valvular atrial fibrillation (AF) and have replaced warfarin as the first line agent of choice. The aim... Read More about Investigating prescribers' experiences of direct-acting oral anticoagulants for the management of nonvalvular atrial fibrillation..

Prescribers' views and experiences of using direct acting oral anticoagulants in the management of nonvalvular atrial fibrillation: a survey in remote and rural Scotland. (2019)
Journal Article
GENERALOVA, D., CUNNINGHAM, S., LESLIE, S.J., RUSHWORTH, G., MCIVER, L. and STEWART, D. 2019. Prescribers’ views and experiences of using direct acting oral anticoagulants in the management of nonvalvular atrial fibrillation: a survey in remote and rural Scotland. British journal of clinical pharmacology [online], 85(10), pages 2414-2422. Available from: https://doi.org/10.1111/bcp.14069

A recent systematic review highlighted the lack of robust studies on prescribers' perspectives of direct-acting oral anticoagulants (DOACs) for non-valvular atrial fibrillation (AF). The aim was to determine prescribers' views and experiences of pres... Read More about Prescribers' views and experiences of using direct acting oral anticoagulants in the management of nonvalvular atrial fibrillation: a survey in remote and rural Scotland..